Form 4 · Filed Jun 5, 2026, 09:26 PM UTC
CVKD/Cadrenal Therapeutics, Inc.
Pham Quang X — CEO and Chairman
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | S | sell | 2,064 | $4 | $9,123 | 173,224 |
| Jun 4, 2026 | S | sell | 3,898 | $4 | $17,190 | 175,288 |
| Jun 3, 2026 | S | sell | 2,323 | $4 | $9,896 | 179,186 |
Source: SEC EDGAR raw filing ↗ · Accession 0001213900-26-065925